REBECCA BIGNESS: Open Payments
NPI 1992322069 · WEEDSPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 22 payments from 13 companies in 2025. Trend: 2023 $509 · 2024 $303 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $150 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Seqirus USA Inc | 2 | $52 |
| Corcept Therapeutics | 2 | $51 |
| Exact Sciences Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: AVYCAZ, TRELEGY ELLIPTA, MOUNJARO, Flucelvax, Korlym, The Cologuard Plus Collection Kit, JOURNAVX, QULIPTA.
Industry payments across NY — which companies pay providers there.
